Since common allergies are mediated primarily by IgE antibodies, the objectives of the investigations are (i) the further elucidation of the cellular mechanisms underlying the production of this class of antibodies, and (ii) the synthesis of appropriate conjugates of monomethoxypolyethylene glycol (mPEG) and polyvinyl alcohol (PVA), respectively, with allergens and haptens, which are capable of specifically suppressing the formation of IgE antibodies. Such mPEG conjugates have been shown to abrogate the induction of IgE and IgG antibodies if administered prior to sensitization, but to enhance the production of IgG (i.e., blocking or protective) antibodies in both allergic patients and animals if administered after sensitization. Studies are proposed to unravel the cellular basis for this dual immunological potential of mPEG conjugates which may reflect the heterogeneity of different subpopulations of B cells with respect to their state of differentiation and their reactivity with these conjugates. As a result of the chemical modification of allergens by coupling to mPEG, the products are safer for injection into patients in much higher doses than conventional allergenic extracts. The results of ongoing clinical trials performed in different countries (under the aegis of Pharmacia AB of Uppsala) are promising, in that the patients so treated appeared to have fewer symptoms and required less medication. The effectiveness of mouse monoclonal antibodies (MoAbs), which are being increasingly used for diverse therapeutic purposes in man (in particular in relation to organ transplantation, tumor localization and destruction) is counteracted by their inherent immunogenicity. Preliminary results in our laboratory indicate that this complication can be overcome by pretreatment of the recipients of MoAbs with mPEG conjugates of MoAbs. The use of tolerogenic mPEG conjugates is being also extended to include mPEG derivatives of natural xenogeneic hormones or of diverse biologically active factors synthesized by recombinant DNA technology, which are immunogenic as has been demonstrated for human growth hormone (GH) and insulin. Studies have just been initiated in this laboratory for the synthesis of tolerogenic conjugates of GH.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI014526-11
Application #
3125781
Study Section
Immunological Sciences Study Section (IMS)
Project Start
1978-01-01
Project End
1989-12-31
Budget Start
1988-01-01
Budget End
1988-12-31
Support Year
11
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Manitoba
Department
Type
DUNS #
207584707
City
Winnipeg
State
MB
Country
Canada
Zip Code
R3 2N2
Takata, M; Maiti, P K; Bitoh, S et al. (1991) Downregulation of helper T cells by an antigen-specific monoclonal Ts factor. Cell Immunol 137:139-49
Takata, M; Maiti, P K; Kubo, R T et al. (1990) Cloned suppressor T cells derived from mice tolerized with conjugates of antigen and monomethoxypolyethylene glycol. Relationship between monoclonal T suppressor factor and the T cell receptor. J Immunol 145:2846-53
Mokashi, S; Holford-Strevens, V; Sterrantino, G et al. (1989) Down-regulation of secondary in vitro antibody responses by suppressor T cells of mice treated with a tolerogenic conjugate of ovalbumin and monomethoxypolyethylene glycol, OVA(mPEG)13. Immunol Lett 23:95-102
Wei, B Y; Holford-Strevens, V; Sehon, A H (1988) Suppression of the murine anti-trimellityl (TM) IgE response: induction of B cell tolerance by conjugates of TM and polyvinyl alcohol. Int Arch Allergy Appl Immunol 85:1-7
Wilkinson, I; Jackson, C J; Lang, G M et al. (1987) Tolerance induction in mice by conjugates of monoclonal immunoglobulins and monomethoxypolyethylene glycol. Transfer of tolerance by T cells and by T cell extracts. J Immunol 139:326-31
Holford-Strevens, V; Jackson, C J; Charlton, J et al. (1987) Induction of in vivo helper activity for murine antibody responses by macrophages pulsed with ovalbumin-monomethoxypolyethylene glycol (OA-mPEG) conjugates. Cell Immunol 104:245-54
Wilkinson, I; Jackson, C J; Lang, G M et al. (1987) Tolerogenic polyethylene glycol derivatives of xenogeneic monoclonal immunoglobulins. Immunol Lett 15:17-22
Jackson, C J; Charlton, J L; Kuzminski, K et al. (1987) Synthesis, isolation, and characterization of conjugates of ovalbumin with monomethoxypolyethylene glycol using cyanuric chloride as the coupling agent. Anal Biochem 165:114-27
Bose, R; Holford-Strevens, V; Sehon, A H (1986) The influence of antibody affinity on the radioallergosorbent test (RAST) and in vitro histamine release. Studies with hapten-specific monoclonal IgE antibodies. J Immunol Methods 89:249-55